In April, McDermott was pleased to once again host our annual European Health & Life Sciences Symposium in Paris. Welcoming a crowd of more than 300 innovators, investors, business leaders and advisers from across the...more
5/13/2025
/ Acquisitions ,
Biotechnology ,
EU ,
Financing ,
Investment ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Private Equity ,
Venture Capital
In April 2025, we were proud to host the annual European Health & Life Sciences Symposium at the Shangri-La hotel in Paris. Attended by some 300 delegates from across the industry, participants including investors,...more
5/5/2025
/ Artificial Intelligence ,
Biologics ,
Biotechnology ,
Clinical Trials ,
Healthcare ,
Healthcare Reform ,
Innovative Technology ,
Investment ,
Investors ,
Life Sciences ,
Pharmaceutical Industry ,
Regulatory Requirements ,
Technology Sector ,
Venture Capital
We can't wait to see you in Paris at our second annual symposium. You'll meet with senior executives in the health, life sciences and private equity industries to identify new investment opportunities and position your...more
10/19/2023
/ Artificial Intelligence ,
Events ,
Financing ,
Health Care Providers ,
Health Information Technologies ,
Healthcare Facilities ,
Investment Opportunities ,
Investors ,
Life Sciences ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds
RUSSIA RESPONDS TO WESTERN SANCTIONS WITH PATENT RETALIATION -
On March 6, 2022, the Russian government retaliated against the West’s imposition of sanctions by issuing a decree permitting patented innovations to be used...more
6/27/2022
/ Appeals ,
Biotechnology ,
Cosmetics ,
Dietary Supplements ,
EU ,
France ,
Intellectual Property Protection ,
Medical Devices ,
Patent Litigation ,
Patent Validity ,
Patents ,
Pharmaceutical Industry ,
Russia ,
Sanctions ,
Trademark Litigation ,
Trademarks
Today’s global healthcare marketplace is marked by unprecedented transformation. This presents both challenges and opportunity to today’s market participants. We know how important it is to structure cross-border investments...more
6/1/2022
/ Anti-Kickback Statute ,
Artificial Intelligence ,
Cross-Border ,
Global Market ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Medical Technology Companies ,
Merger Controls ,
Pharmaceutical Industry ,
Technology Sector ,
Telemedicine
UNIFIED PATENT COURT -
The Unified Patent Court (UPC) should become a reality in 2022 or in the first few months of 2023.
The Protocol on Provisional Application (PPA) of the Agreement on a Unified Patent Court (AUPC)...more
2/21/2022
/ EU ,
France ,
Healthcare ,
Manufacturers ,
Medical Devices ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Trademarks ,
Unfair Competition
Patent and trademark issues effecting pharmaceutical laboratories, biotechs, food supplements and dietary products professionals, cosmetics companies and medical devices manufacturers is continually evolving across France and...more
9/29/2021
/ Counterfeiting ,
EU ,
France ,
Intellectual Property Protection ,
Inventions ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Revocation ,
Trademark Infringement ,
Trademark Invalidity ,
Trademarks
This year, recognising that as we are still unable to meet in person, our HPE Europe EVENT will be going ahead with two exclusive, virtual extended lunch time sessions.
We will be joined by investors including key players...more
6/9/2021
/ Acquisitions ,
Business Valuations ,
Coronavirus/COVID-19 ,
Financing ,
Health Care Providers ,
Healthcare Facilities ,
Hospitals ,
Investment Opportunities ,
Investors ,
Lenders ,
Leveraged Loans ,
Life Sciences ,
Mergers ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Risk Management ,
Webinars
Given the challenges of conducting clinical trials during the COVID-19 pandemic, many countries — including France — have allowed for some use of remote quality controls. In response to guidelines issued recently by European...more
5/5/2021
/ Clinical Trials ,
CNIL ,
Compliance ,
Coronavirus/COVID-19 ,
Data Protection ,
EU ,
France ,
Personal Data ,
Personally Identifiable Information ,
Policies and Procedures ,
Public Health Emergency ,
Quality Control Plan